Details of the Drug
General Information of Drug (ID: DMH7N9A)
| Drug Name |
Sarkomycin
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
Sodium sarkomycin; Sarkomycin; Sarkomycin, sodium salt; Sarkomycin B*, sodium salt; NSC 14347; sodium 2-methylidene-3-oxocyclopentanecarboxylate; 874-21-5; Cyclopentanecarboxylic acid, 2-methylene-3-oxo-, sodium salt; NSC14347; AC1Q1VYY; 489-21-4 (Parent); CHEMBL2028558; CTK8D8157; LS-57900; sodium 2-methylene-3-oxo-1-cyclopentanecarboxylate; A844648; sodium 2-methylidene-3-oxidanylidene-cyclopentane-1-carboxylate
|
||||||||||||||||||
| Indication |
|
||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||
| Drug-Molecule Activity Atlas (DMA)NEW | Click to Jump to the Detailed DMA Information of This Drug | ||||||||||||||||||
| Drug ADMET Endpoint Profile (DAE)NEW | Click to Jump to the Detailed DAE Information of This Drug | ||||||||||||||||||

